We examined EPHB4 mRNA expression in published human prostate cancer expression datasets and observed higher EPHB4 expression in metastatic castration-resistant prostate cancer (mCRPC) as compared to the corresponding normal or primary tumor tissues (Fig. 1a). This evidence concerns the gene EPHB4 and Familial prostate cancer.